LDHA and non-small cell lung carcinoma: In a mouse model of non-small cell lung cancer (NSCLC), the inactivation of LDHA decreased the proliferation and survival of tumor cells [202], resulting in a reduction in tumorigenesis and disease regression, indicating that LDHA has an impact on tumor cell survival and can be a promising target for NSCLC treatment [202].